Genesis Molecular Technologies, Inc.

City:

Austin, Texas

Country:

United States

Published Applications:

Last publication date:

2023-11-23

Patent Grants:

Last grant date:

2024-12-17

Top Inventors for applications by Genesis Molecular Technologies, Inc.

These are the the leading inventors for applications assigned to Genesis Molecular Technologies, Inc.:

Fuqiang RUAN 2 Bellevue, WA United States

Recent patent applications by Genesis Molecular Technologies, Inc.

Genesis Molecular Technologies, Inc. based in Austin, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-11-23 ✅ Patent 12,168,665 granted on 2024-12-17

US20230374020A1

Chemistry; metallurgy

Substituted imidazo[l,2-a]pyrazines and pyrazino[l,2-a] pyrimidines as topical agents for dermatological applications

#2 | 2022-04-07 ✅ Patent 11,639,356 granted on 2023-05-02

US20220106320A1

Chemistry; metallurgy

Substituted imidazo[1,2-a]pyrazines and pyrazino[1,2-a]pyrimidines as topical agents for dermatological applications

Also check out Genesis Molecular Technologies, Inc.'s (Austin, United States) applicant profile with 2 patent applications submitted.

AssigneeID:

598713 ⎘